Search
Contineum Therapeutics Inc
CTNMAdd to Watchlist
15.100USD
-0.140-0.92%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
563.53MMarket Cap
LossP/E TTM
Contineum Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Contineum Therapeutics Inc is 7.55, ranking 217 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.81, which is -450.07% below the recent high of 27.33 and -125.53% above the recent low of -17.61.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.